CN113423428A - 刺激感得到了抑制的眼科组合物 - Google Patents
刺激感得到了抑制的眼科组合物 Download PDFInfo
- Publication number
- CN113423428A CN113423428A CN202080013192.3A CN202080013192A CN113423428A CN 113423428 A CN113423428 A CN 113423428A CN 202080013192 A CN202080013192 A CN 202080013192A CN 113423428 A CN113423428 A CN 113423428A
- Authority
- CN
- China
- Prior art keywords
- component
- ophthalmic composition
- irritation
- group
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019-043089 | 2019-03-08 | ||
JP2019043089 | 2019-03-08 | ||
JP2019-071396 | 2019-04-03 | ||
JP2019071396 | 2019-04-03 | ||
PCT/JP2020/009847 WO2020184479A1 (ja) | 2019-03-08 | 2020-03-06 | 刺激感が抑制された眼科組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113423428A true CN113423428A (zh) | 2021-09-21 |
Family
ID=72427534
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202080013192.3A Pending CN113423428A (zh) | 2019-03-08 | 2020-03-06 | 刺激感得到了抑制的眼科组合物 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPWO2020184479A1 (ru) |
CN (1) | CN113423428A (ru) |
TW (1) | TW202100144A (ru) |
WO (1) | WO2020184479A1 (ru) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09132526A (ja) * | 1995-11-09 | 1997-05-20 | Lion Corp | 点眼剤 |
JP2003183157A (ja) * | 2001-12-19 | 2003-07-03 | Lion Corp | 眼科用組成物 |
JP2006176501A (ja) * | 2004-11-26 | 2006-07-06 | Taisho Pharmaceut Co Ltd | 眼科用剤 |
JP2009029779A (ja) * | 2007-06-29 | 2009-02-12 | Rohto Pharmaceut Co Ltd | レボカバスチン及び/又はその塩を含有する水性医薬組成物 |
JP2011074092A (ja) * | 2003-04-04 | 2011-04-14 | Rohto Pharmaceutical Co Ltd | 眼科用組成物 |
CN104039315A (zh) * | 2012-01-05 | 2014-09-10 | 花王株式会社 | 用于降低感觉刺激的制剂 |
CN104918599A (zh) * | 2012-05-25 | 2015-09-16 | 宝洁公司 | 用于减少trpa1和trpv1感觉的组合物 |
WO2018009717A1 (en) * | 2016-07-06 | 2018-01-11 | Algomedix, Inc. | Trpa1 antagonists for treatment of dry eye, ocular pain and inflammation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2620137B1 (de) * | 2012-01-30 | 2017-11-15 | Symrise AG | Zubereitungen |
JP5730355B2 (ja) * | 2013-07-24 | 2015-06-10 | 学校法人近畿大学 | Cyp2a13阻害剤 |
EP3093002B1 (de) * | 2015-05-15 | 2018-04-25 | Symrise AG | Flüssige kühlstoffzubereitungen |
-
2020
- 2020-03-06 JP JP2021505049A patent/JPWO2020184479A1/ja active Pending
- 2020-03-06 TW TW109107480A patent/TW202100144A/zh unknown
- 2020-03-06 CN CN202080013192.3A patent/CN113423428A/zh active Pending
- 2020-03-06 WO PCT/JP2020/009847 patent/WO2020184479A1/ja active Application Filing
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09132526A (ja) * | 1995-11-09 | 1997-05-20 | Lion Corp | 点眼剤 |
JP2003183157A (ja) * | 2001-12-19 | 2003-07-03 | Lion Corp | 眼科用組成物 |
JP2011074092A (ja) * | 2003-04-04 | 2011-04-14 | Rohto Pharmaceutical Co Ltd | 眼科用組成物 |
JP2006176501A (ja) * | 2004-11-26 | 2006-07-06 | Taisho Pharmaceut Co Ltd | 眼科用剤 |
JP2009029779A (ja) * | 2007-06-29 | 2009-02-12 | Rohto Pharmaceut Co Ltd | レボカバスチン及び/又はその塩を含有する水性医薬組成物 |
CN104039315A (zh) * | 2012-01-05 | 2014-09-10 | 花王株式会社 | 用于降低感觉刺激的制剂 |
CN104918599A (zh) * | 2012-05-25 | 2015-09-16 | 宝洁公司 | 用于减少trpa1和trpv1感觉的组合物 |
WO2018009717A1 (en) * | 2016-07-06 | 2018-01-11 | Algomedix, Inc. | Trpa1 antagonists for treatment of dry eye, ocular pain and inflammation |
Also Published As
Publication number | Publication date |
---|---|
TW202100144A (zh) | 2021-01-01 |
WO2020184479A1 (ja) | 2020-09-17 |
JPWO2020184479A1 (ru) | 2020-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6359586B2 (ja) | 眼科組成物 | |
JP5616620B2 (ja) | 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物 | |
JP6148957B2 (ja) | プラノプロフェン含有水性組成物 | |
JP2024061871A (ja) | 眼科組成物 | |
JP2003206241A (ja) | 眼科用剤 | |
US20230172969A1 (en) | Ophthalmic Composition | |
JP2016179960A (ja) | 眼科用組成物 | |
RU2670100C2 (ru) | Офтальмическая композиция для цвиттерионных мягких контактных линз | |
CN113423428A (zh) | 刺激感得到了抑制的眼科组合物 | |
JP6687781B1 (ja) | 刺激感が抑制された眼科組成物 | |
JP2022191328A (ja) | 水性組成物 | |
JP2023033557A (ja) | 複合目症状改善用眼科組成物 | |
JP6983009B2 (ja) | 眼科組成物 | |
RU2677665C2 (ru) | Офтальмическая композиция для анионных мягких контактных линз | |
JP7049083B2 (ja) | 眼科組成物 | |
JP2021031431A (ja) | 点眼剤 | |
JP5019923B2 (ja) | プラノプロフェン含有医薬組成物 | |
JP6913792B2 (ja) | 局所粘膜適用水性組成物 | |
JP6401699B2 (ja) | 両性イオン性ソフトコンタクトレンズ用眼科用組成物 | |
JP6732441B2 (ja) | 局所粘膜適用水性組成物 | |
WO2013065719A1 (ja) | 眼科用水性組成物 | |
JP2021187857A (ja) | ソフトコンタクトレンズ用眼科組成物 | |
JP2011026285A (ja) | プラノプロフェン含有水性組成物 | |
JP2017197527A (ja) | 眼科組成物 | |
JP2019142855A (ja) | 点眼剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
CB03 | Change of inventor or designer information |
Inventor after: Haga Masato Inventor after: Ito Keisuke Inventor after: Harinikawa Yuko Inventor before: Haga Masato |
|
CB03 | Change of inventor or designer information | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40058186 Country of ref document: HK |